S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment.

Trial Profile

S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Jul 2017

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Advanced breast cancer; Cancer metastases; Lung cancer; Multiple myeloma; Prostate cancer; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Jan 2018.
    • 12 Jul 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jan 2018.
    • 04 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top